London, 10 June 2014 -- Moody's Investors Service has today downgraded to Ba2(sf) from Baa2(sf) the rating of the Class C notes issued by Pharma Finance 2 S.r.l. Very high debtor concentrations and deteriorating performance primarily drove the rating action.
Vollständigen Artikel bei Moodys lesen